Advances in cerebrovascular reserve function assessment for moyamoya disease

Siyu Chen1,2, Tianrui Yu1,2, Yuanyuan Xiang2

  • 1Department of Neurology, School of Clinical Medicine, Jiujiang University, Jiujiang, Jiangxi, China.

BMJ Neurology Open
|July 17, 2026
PubMed

Insights

Moyamoya disease (MMD) progression is hard to track, increasing stroke risk. Cerebrovascular reserve (CVR) assessment offers a way to evaluate MMD severity and guide treatment for better patient outcomes.

Area of Science:

  • Neurology
  • Vascular Biology
  • Medical Imaging

Background:

  • Moyamoya disease (MMD) involves progressive stenosis of major cerebral arteries, leading to fragile collateral networks.
  • MMD significantly increases the risk of ischemic or hemorrhagic stroke.
  • Current methods for assessing MMD progression and stroke risk are insufficient, delaying critical interventions.

Purpose of the Study:

  • To review current literature on cerebrovascular reserve (CVR) assessment techniques in Moyamoya disease.
  • To analyze the advantages and disadvantages of different CVR evaluation methods.
  • To discuss the role of CVR in monitoring MMD progression and guiding treatment strategies.

Main Methods:

  • Narrative review of recent scientific literature.
  • Analysis of various CVR assessment techniques.
  • Discussion of the relationship between CVR and MMD pathology.

Main Results:

  • Cerebrovascular reserve (CVR) reflects the brain's capacity to augment blood flow under stress.
  • CVR evaluation is crucial for understanding MMD severity and prognosis.
  • Different CVR assessment techniques have distinct benefits and limitations.

Conclusions:

  • Accurate assessment of CVR is vital for managing Moyamoya disease.
  • Understanding CVR aids in predicting stroke risk and optimizing therapeutic decisions.
  • Further research into CVR assessment methods can improve clinical management of MMD patients.

Related Concept Videos